SLNSW-Prices and clinical benefit of cancer drugs in th...-TN_cdi_proquest_miscellaneous_2398154269

Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

Full title: Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

Author/creator: Vokinger, Kerstin N, Hwang, Thomas J, Grischott, Thomas, Reichert, Sophie, Tibau, Ariadna, Rosemann, Thomas, Kesselheim, Aaron S.

Call Numbers:

Record Identifier: TN_cdi_proquest_miscellaneous_2398154269

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154269

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

    Record identifier

    TN_cdi_proquest_miscellaneous_2398154269

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154269

    Share

    Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154269

    Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

    Full title

    Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

    Author / Creator

    Vokinger, Kerstin N ; Hwang, Thomas J ; Grischott, Thomas ; Reichert, Sophie ; Tibau, Ariadna ; Rosemann, Thomas ; Kesselheim, Aaron S

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2020, Vol.21 (5), p.664-670

    Record Identifier

    TN_cdi_proquest_miscellaneous_2398154269

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Antimitotic agents Antineoplastic agents Cancer Cancer therapies Drug approval FDA approval Oncology Pharmaceutical industry Prices and rates Regression analysis Regulatory reform Solid tumors Studies

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_miscellaneous_2398154269

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2398154269

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections